PrecisionPoint® is saving men’s lives around the world. Don’t put yourself at risk, if you or a loved one needs a prostate biopsy, find a PrecisionPoint® provider near you. Contact us at . #urology #menshealth #prostatecancer #cancer #transperineal

PrecisionPoint® was engineered by Dr. Matthew Allaway to address real limitations of existing solutions. “They’re all gone now,” says Dr. Walter, who has been both a provider and patient of PrecisionPoint®. Learn more at #urology #medicalInnovation

Join millions who have switched to Grok.

Prostate cancer is likely to affect you or someone you know. It’s important to know the risks associated with prostate biopsy methods, which play a critical role in diagnosing prostate cancer. Learn more at . #ProstateHealth ##EarlyDetection #MensHealth

A prostate biopsy doesn’t have to feel uncertain. PrecisionPoint® gives you the clarity—and the confidence—to move forward. Ask your doctor about the safer, FDA-cleared alternative. Learn more at #PrecisionPoint #ProstateHealth #SaferBiopsy #MensHealth

This weekend! Come check us out at the Advance Urology Institute Annual Meeting in Orlando and learn more about a better, safer prostate biopsy™. 📍Waldorf Astoria Orlando. #Urology #MedicalInnovation #PrecisionPoint® #AUI

³ Grummet, J., Gorin, M.A., Popert, R. et al. “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis 23, 62–65 (2020).

² Forsvall A, Jönsson H, Wagenius M, Bratt O, Linder A. Rate and characteristics of infection after transrectal prostate biopsy: a retrospective observational study. Scand J Urol. 2021 Aug;55(4):317-323. doi: 10.1080/21681805.2021.1933169. Epub 2021 Jun 7. PMID: 34096449.

¹ Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer. Clin Genitourin Cancer. 2017 Feb;15(1):e33-e36. doi: 10.1016/j.clgc.2016.07.007. Epub 2016 Jul 21. PMID: 27530436.

Looking for a safer biopsy? New options are available at #saferBiopsy #menshealth #prostateCancer #PrecisionPoint®.

DISCLAIMER:.Some studies find that transrectal prostate biopsies may be associated with certain risks, such as. ❌ Missing cancers in the anterior region¹.❌ Contaminating the bloodstream with fecal matter, causing infection².❌ Increasing Antibiotic-resistant sepsis³

Ready to make the transformation? Get started at #urology #medicalInnovation #PrecisionPoint®.

Transperineal is the future, and for many, it's already the present. At Guy’s Hospital in London, urologists completely replaced transrectal prostate biopsies with the PrecisionPoint® access system. They found PrecisionPoint® checked the boxes:.✅ Safe.✅ Tolerable.✅ Effective

This weekend! Come check us out at the Annual West Virginia Urologic Association Meeting and learn more about a better, safer prostate biopsy™. 📍Stonewall Jackson Resort. #Urology #MedicalInnovation #PrecisionPoint® #UAM

James Allegra was eager to share his story, letting us know how important it was to warn others of the risks he said no one told him about. Listen to the full interview at . Learn about PrecisionPoint® at

The data is clear: Transperineal is cleaner. Safer. Smarter. 🔗 Learn more at Read the study here: #Urology #Transperineal #ProstateBiopsy #PatientSafety #InfectionFree #SepsisPrevention #PrecisionPoint®.

In a recent outpatient series using PrecisionPoint® under local anesthesia, not a single patient (n=72) developed post-biopsy infection or sepsis. Contrast that with the 2.0% sepsis rate previously observed at the same facility using the transrectal approach.

Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer. Clin Genitourin Cancer. 2017 Feb;15(1):e33-e36. doi: 10.1016/j.clgc.2016.07.007. Epub 2016 Jul 21. PMID: 27530436.

Patients are increasingly aware of the risks associated with traditional prostate biopsies. Thankfully, PrecisionPoint® virtually eliminates the risk of infection and improves access to cancers often missed by traditional biopsies. Learn more at

Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer. Clin Genitourin Cancer. 2017 Feb;15(1):e33-e36. doi: 10.1016/j.clgc.2016.07.007. Epub 2016 Jul 21. PMID: 27530436.

Many doctors have heard that transperineal is associated with reduced infection risk, but did you know that it’s also associated with better access to the anterior region of the prostate? . Learn more at